| Financial Year |
March 31 2023 |
| Monetary Funds |
773,538,041.68 |
| Held-for-trading Financial Assets |
80,048,789.04 |
| Notes Receivable |
-- |
| Accounts Receivable |
732,990,860.94 |
| Advances to Suppliers |
60,847,049.48 |
| Other Receivables |
83,055,502.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
8,716,318.55 |
| Inventories |
210,699,216.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,419,512.84 |
| Total Current Assets |
1,953,598,972.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
160,104,507.31 |
| Investment Properties |
101,070,642.43 |
| Fixed Assetes |
802,970,694.79 |
| Under-construction Projects |
231,354,955.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,210,062.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,739,830.48 |
| Deferred Income Tax Assets |
28,857,246.28 |
| Other Non-Current Assets |
13,480,023.48 |
| Sub-Total of Non-Current Assets |
1,519,450,528.06 |
| Total Assets |
3,473,049,501.05 |
| Short-Term Loans |
145,130,419.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
317,155,347.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,190,939.92 |
| Taxes Payable |
44,446,274.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
84,349,328.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
76,554,055.85 |
| Other Current Liabilities |
8,030,705.51 |
| Sub-Total of Current Liabilities |
815,522,300.58 |
| Long-term Loans |
7,040,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,619,875.40 |
| Deferred Income Tax Liabilities |
41,810,594.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
87,133,900.51 |
| Total Liabilities |
902,656,201.09 |
| Paid-In Capital(Or Share Stock) |
382,999,815.00 |
| Capital Surplus |
1,116,761,560.94 |
| Surplus Reserve |
121,181,021.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
985,223,065.80 |
| Minority Stockholder's Interest |
-11,263,150.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,581,656,450.32 |
| Owner's Equity（Stockholder's Equity） |
2,570,393,299.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,473,049,501.05 |
